Although several biomarkers have been studied for mesothelioma such as mesothelin, fibulin-3, microRNAs (miRNAs), soluble mesothelin-related peptides (SMRPs), and high mobility group box 1 (HMGB1), only a few have shown consistent clinical relevance. The gene discussed is HMGB1; the disease is mesothelioma.